1 Min Read
Aug 29 (Reuters) - Austar Lifesciences Ltd
* HY revenue RMB244.9 million versus RMB289.8 million
* HY loss attributable to the owners of the company RMB25.1 million versus loss of RMB12.1 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.